Equities

Medical System Network Co Ltd

Medical System Network Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)620.00
  • Today's Change-7.00 / -1.12%
  • Shares traded7.60k
  • 1 Year change+53.85%
  • Beta1.0338
Data delayed at least 20 minutes, as of Apr 26 2024 03:13 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MEDICAL SYSTEM NETWORK Co., Ltd. is mainly engaged in the operation of dispensing pharmacy business. The Company operates in five business segments. The Pharmaceutical Product Network segment involves in ordering system of medicines, development and sale of systems, and support services for securitized receivables. The Dispensing Pharmacy segment operates and manages dispensing pharmacies. The Leasing and Equipment-related Business segment involves in the location development of pharmacies, the rental of buildings for clinics, and the operation of buildings and housing for the elderly. The Food Supply segments provides food service within hospitals and welfare facilities. The Others segment involves in clinical trial support services and visiting nursing services.

  • Revenue in JPY (TTM)113.85bn
  • Net income in JPY2.11bn
  • Incorporated1999
  • Employees3.62k
  • Location
    Medical System Network Co Ltd6F, AKK Bldg.24-3, Kita-Jujo Nishi, Chuo-kuSAPPORO-SHI 060-0010JapanJPN
  • Phone+81 116121069
  • Fax+81 116121068
  • Websitehttps://www.msnw.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4350:TYO since
announced
Transaction
value
PharmaShift Co LtdDeal completed07 Nov 202307 Nov 2023Deal completed32.20%--
Data delayed at least 20 minutes, as of Apr 26 2024 03:13 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sapporo Clinical Laboratory Inc19.73bn387.40m4.56bn938.009.300.33235.110.2312116.33116.335,924.573,256.381.1719.476.4321,034,420.002.175.322.826.8630.0431.791.863.861.99287.440.16888.715.332.88-45.48-3.6621.1915.90
Sophia Holdings Co Ltd9.04bn29.33m4.99bn215.00116.451.4611.360.55239.569.563,257.88764.761.2410.417.1442,026,600.000.40162.380.65834.3337.2534.110.32461.931.2013.400.53240.00-20.0419.85-96.56-48.3044.35--
Pharmarise Holdings Corp53.97bn302.00m7.86bn1.56k24.440.93115.300.145726.6826.684,651.75700.242.1914.0890.6434,709,970.001.281.482.042.4415.8915.110.58550.69420.966536.970.570536.130.8177-0.9458-25.50--6.000.00
Medical Ikkou Group Co Ltd39.90bn1.04bn10.07bn1.30k8.940.70255.400.2525276.70276.7010,618.433,523.261.3523.727.22--3.663.115.394.5211.4110.522.712.551.44--0.40918.0117.715.0336.897.88-21.672.38
Hyuga Primary Care Co Ltd7.83bn439.66m12.22bn442.0028.617.8720.871.5658.9358.931,046.57214.252.2623.005.9217,718,790.0012.69--25.09--22.32--5.61--1.08177.780.3316--15.13--16.57------
J Frontier Co Ltd17.01bn-1.71bn12.55bn255.00--4.38--0.7378-360.79-360.793,528.98558.332.076.999.2566,696,210.00-20.89---35.65--46.62---10.10--0.9656-77.390.5128--41.83---574.36------
Satudora Holdings Co Ltd94.04bn359.00m13.24bn1.11k35.771.417.850.140826.0026.006,807.01658.512.166.4735.7884,950,320.000.84680.68451.651.2624.1224.300.39240.30450.43488.160.652657.985.522.19-72.47-10.203.351.39
Medical System Network Co Ltd113.85bn2.11bn19.30bn3.62k9.021.223.690.169669.8569.853,772.48515.661.6710.6232.3431,458,410.003.121.774.832.7241.7440.131.861.100.613813.550.602628.572.693.11-32.759.52-17.643.71
Nihon Chouzai Co Ltd334.60bn3.94bn46.94bn5.69k11.490.76013.670.1403131.63131.6311,184.721,989.181.756.4414.9958,815,430.002.062.433.594.1416.6917.341.181.580.542725.330.467716.934.655.3620.32-6.09-9.440.00
Yakuodo Holdings Co Ltd142.24bn3.83bn55.39bn969.0014.371.658.340.3894195.20195.207,259.051,700.132.054.8587.88--5.525.548.438.6721.5722.402.692.720.3559168.030.289814.3610.449.1518.025.37-15.284.36
Cawachi Ltd285.23bn4.38bn65.00bn2.77k13.510.53267.500.2279195.71195.7112,756.434,964.621.426.1941.31102,970,000.002.172.323.263.4622.8622.311.531.590.8148526.770.142224.490.8620.9989-13.521.54-1.272.13
Qol Holdings Co Ltd178.46bn5.27bn69.05bn5.75k12.521.286.610.3869141.81141.814,801.101,384.571.6121.8710.7131,058,650.004.764.707.907.5413.0713.202.952.840.9217--0.362524.302.313.163.042.5520.482.90
Data as of Apr 26 2024. Currency figures normalised to Medical System Network Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

14.43%Per cent of shares held by top holders
HolderShares% Held
Samarang LLPas of 15 Jun 20231.79m5.85%
Nomura Asset Management Co., Ltd.as of 29 Mar 2024735.20k2.40%
SPARX Asset Management Co., Ltd.as of 23 Jan 2023485.60k1.59%
Dimensional Fund Advisors LPas of 04 Apr 2024409.00k1.34%
Nikko Asset Management Co., Ltd.as of 05 Apr 2024395.50k1.29%
Daiwa Asset Management Co. Ltd.as of 29 Mar 2024339.00k1.11%
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 2024127.90k0.42%
BlackRock Japan Co. Ltd.as of 04 Apr 202454.60k0.18%
Norges Bank Investment Managementas of 31 Dec 202342.60k0.14%
Dimensional Fund Advisors Ltd.as of 04 Apr 202440.06k0.13%
More ▼
Data from 30 Jun 2022 - 18 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.